AstraZeneca's blockbuster breast cancer drug will be added to China's national reimbursement scheme list, according to an ...

AstraZeneca's Fasenra, an injectable treatment for severe asthma, is more effective during attacks than the oral steroid that ...

AstraZeneca's blockbuster breast cancer drug will be added to China's national reimbursement scheme list, according to an ...

AstraZeneca's (NASDAQ:AZN) blockbuster cancer medication, Enhertu, developed with Japanese pharma giant Daiichi Sankyo (OTCPK ...

China: Enhertu, a blockbuster breast cancer drug of AstraZeneca, will be included in China's state-run health insurance ...

AstraZeneca (AZN) reported positive results from a Phase 3 study of its drug Truqap in the treatment of a certain type of ...

AstraZeneca Pharmaceuticals LP violated federal and Ohio law when it denied a Christian sales specialist an exemption from ...

Dr. Bob Li, a top Asian leader from the New York-based Memorial Sloan Kettering Cancer Center, has become global head of ...

A new study, supported by AstraZeneca, has shown that a single dose of benralizumab significantly reduces treatment failure ...

AstraZeneca PLC AZN shares were unchanged Monday at £104.74, on what proved to be an all-around great trading session for the ...

The market seemed underwhelmed by last week's earnings announcement from AstraZeneca PLC ( LON:AZN) despite the healthy ...

The failure of the trial of the drug AZD4041 by pharma giant AstraZeneca, to combat opioid use disorder (OUD), highlights the ...